Sodium cloprostenol administered at a continuous low dosage induces polydipsia and suppresses luteal function in early dioestrous bitches

Animal Reproduction Science

Volumn 67, Issue 1-2, 2001, Pages 113-123

  Watts, J R ^a   Wright, P J ^b   Parry, B W ^b  

^a Veterinary Clinical Centre   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cloprostenol; Dog; Luteolysis; Polydipsia; Prostaglandin F2 ; Pyometra

Indexed keywords

CLOPROSTENOL; PROGESTERONE; UREA;

ANIMAL; ARTICLE; BLOOD; BODY WEIGHT; CORPUS LUTEUM; DIESTRUS; DOG; DRINKING; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; KINETICS; PHYSIOLOGY; URINALYSIS;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CLOPROSTENOL; CORPUS LUTEUM; DIESTRUS; DOGS; DRINKING; FEMALE; KINETICS; PROGESTERONE; UREA; URINALYSIS;

CANIDAE; CANIS FAMILIARIS;

EID: 0035800159     PISSN: 03784320     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4320(01)00111-7     Document Type: Article

References (35)

1. Evidence for an in vivo antagonism between vasopressin and prostaglandin in the mammalian kidney
2. Use of low dose prostaglandin for the treatment of canine pyometra
3. Renal function in dogs with pyometra. 2. Concentration and diluting ability
4. Renal function in dogs with pyometra 3. Glomerular filtration rate, effective renal plasma flow, and the relation between solute excretion rate and maximum urine osmolarity during dehydration
5. Renal function in dogs with pyometra 5. Sodium content of the renal medulla in relation to concentrating ability
6. Renal function in dogs with pyometra 6. Sodium excretion during osmotic diuresis and its relation to the renal dysfunction
7. Renal function in dogs with pyometra 8. Uterine infection and the pathogenesis of the renal dysfunction
8. Pathogenesis of renal damage and polydipsia in dogs with pyometra
9. Prostaglandin F2α induced luteolysis, hypothermia and abortions in beagle bitches
10. Urinary system
11. Prostaglandin induction of abortion in pregnant bitches after misalliance
12. Clinical protocol for pregnancy termination in bitches using prostaglandin F2α
13. Modification, by aspirin and indomethacin, of the haemodynamic and prostaglandin releasing effects of E. coli endotoxin in the dog
14. E. coli endotoxin shock in the dog treatment with lidocaine or indomethacin
15. A retrospective study of 40 cases of canine pyometra-metritis treated with prostaglandin F-2α and broad spectrum antibacterial drugs
16. Effects of prostaglandins E1, A1 and F2α on renal handling of salt and water
17. Prostaglandins in pyometrial fluid from the cow, bitch and ferret
18. Prostaglandin therapeutics in the bitch and queen
19. Onset of diestrus in the beagle bitch - Definition and significance
20. A preliminary study of pregnancy termination in the bitch with slow-release formulations of prostaglandin analogues
21. Effects of low doses of prostaglandin F2α during the early luteal phase before and after implantation in beagle bitches
22. Polyuria and polydipsia
23. Clinical experience with prostaglandin F2α tham as a luteolytic agent in pregnant and non-pregnant beagle bitches
24. Luteolysis in early dioestrous beagle bitches
25. Effects of prostaglandin F2α on corpora lutea formation and function in mated bitches
26. Clinical use of prostaglandin F2α to induce early abortion in bitches: Serum progesterone, treatment outcome and interval to subsequent oestrus
27. Induction of abortion in the bitch with a synthetic prostaglandin analog
28. Effect of prostaglandin F2α-tham in the bitch
29. Renal dysfunction in bitches with pyometra
30. Pyometra in the bitch - Cytological, bacterial, histological and endocrinological characteristics
31. Calcium cloprostenol administered at continuous low dosage induces luteolysis and abortion in bitches
32. Uterine, cervical and vaginal microflora of the normal bitch throughout the reproductive cycle
33. Antiendotoxin immunotherapy for canine pyometra endotoxemia
34. Practical aspects on the estimation of the time of ovulation and of insemination in the bitch
35. Mechanisms of the natiuretic and diuretic effects of prostaglandin F2α